Genmab — Juli 2020
-
Fred være med det.
-
Må dog konstatere at Novo, GEN, ZEAL, BAVA og AMBU falder i åbningen. Så mange kan der da ikke være som læser Jyllandspostens finansside.
-
Lancet - Hyper-CVAD regimen in combination with ofatumumab as frontline therapy for adults with Philadelphia chromosome-negative B-cell acute lymphoblastic leukaemia: a single-arm, phase 2 trial https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(20)30144-7/fulltext
-
Nogen estimater på Q2 salgstal torsdag? Jeg lægger ud gæt med USD 980M!
-
DnB Markets
Rune Majlund Dahl
Genmab (Hold, TP: DKK2400.00) - Limited Covid-19 impact
We expect slightly lower Darzalex sales in Q2 QOQ due to Covid-19, and estimate global sales of USD936m. We are at the mid-point of the USD3.9bn–4.2bn sales guidance for 2020e. -
-
another PET/CT Scan trial With the Radioactive Tracer 89Zr-DFO-Daratumumab https://clinicaltrials.gov/ct2/show/NCT04467281?term=genmab+OR+daratumumab+OR+darzalex+OR+ofatumumab+OR+Teprotumumab+OR+Tisotumab+OR+camidanlumab+OR+Enapotamab+OR+ADCT-301+OR+duobody&lupd_s=07%2F13%2F2020&draw=2&rank=1
-
Servicemeddelse: Jeg har lavet to chats til Finans- og Økonomikalendere. Jeg opdaterer disse løbende frem over.
-
God morgen.
-
Pensionist...Det er i kronogisk orden, men er svært at læse. Det bliver bedre. Det er foreløbigt blot en test. Det er meningen at der kun bliver slået en dag ad gangen op. Det er mere overskueligt.
-
Foreløbigt er det en nødløsning til vi får råd til en bedre teknisk løsning.
-
An evaluation of subcutaneous daratumumab for the treatment of multiple myeloma
https://www.tandfonline.com/doi/full/10.1080/17474086.2020.1795829 -
full article https://sci-hub.tw/https://www.tandfonline.com/doi/full/10.1080/17474086.2020.1795829 i suggest reading at least the conclusion and expert opinion
-
Thanks E L.
-
Expert opinion
"
Subcutaneous daratumumab is non-inferior to conventional intravenous daratumumab with lower risk of infusion-related reactions and decreased administration time. Based on these data, and the recent FDA and European Commission approvalsthe widespread use of the subcutaneous formulation for both conventional and investigational practice is supported".
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind